# What Most Favored Nation Drug Pricing Would Mean for the US

Page: https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us
Text version: https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us.md
Podcast: [A Health Podyssey](https://stenobird.com/podcast/a-health-podyssey-1366621)
Published: 2026-04-14T04:00:00+00:00
Episode link: https://share.transistor.fm/s/364cdcdb
Audio file: https://media.transistor.fm/364cdcdb/fd8f0aae.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/what-most-favored-nation-drug-pricing-would-mean-for-the-us
Duration seconds: 1435

## Resource

Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/what-most-favored-nation-drug-pricing-would-mean-for-the-us/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.